-
1Academic Journal
Συγγραφείς: Zh. V. Buzitskaya, A. B. Popov, E. A. Romanovskaya-Romanko, M. V. Sergeeva, E. A. Varyushina, M. K. Erofeeva, M. A. Stukova, D. A. Lioznov, Ж. В. Бузицкая, А. Б. Попов, Е. А. Романовская-Романько, М. В. Сергеева, Е. А. Варюшина, М. К. Ерофеева, М. А. Стукова, Д. А. Лиознов
Συνεισφορές: The study was carried out within the government contract of the Ministry of Health of the Russian Federation Assessment of the Intensity of Collective Immunity and Epidemiological Effectiveness of Influenza Vaccines in the Russian Federation (2019-2021)., Работа выполнена в рамках государственного задания Министерства здравоохранения Российской Федерации по теме «Оценка напряженности коллективного иммунитета и эпидемиологической эффективности гриппозных вакцин в Российской Федерации» на 2018-2021 гг.
Πηγή: Medical Immunology (Russia); Том 25, № 4 (2023); 751-758 ; Медицинская иммунология; Том 25, № 4 (2023); 751-758 ; 2313-741X ; 1563-0625
Θεματικοί όροι: критерии иммуногенности, children, adolescents, antibodies, hemagglutination inhibition reaction, immunogenicity criteria, дети, подростки, антитела, реакция торможения гемагглютинации
Περιγραφή αρχείου: application/pdf
Relation: https://www.mimmun.ru/mimmun/article/view/2737/1688; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/11892; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/11893; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/11894; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/11895; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/11896; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/11897; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/11898; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/12167; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/12168; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/12411; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/12412; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/12413; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2737/12456; Black S., Nicolay U., Vesikari T., Knuf M., del Giudice G., della Cioppa G., Tsai T., Clemens R., Rappioli R. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr. Infect. Dis. J., 2011, Vol. 30, no. 12, pp. 1081-1085.; EMA.Note for guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP/214/96. 12 March 1997. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/note-guidance-harmonisation-requirements-influenza-vaccines_en.pdf.; Hinojosa M., Shepard S.S., Chung J.R., King J.P., McLean H.Q., Flannery B., Belongia E.A., Levine M.Z. Impact of immune priming, vaccination, and infection on influenza A(H3N2) antibody landscapes in children. J. Infect. Dis., 2021., Vol. 224, pp. 469-480.; Hobson D., Curry R.L., Beare A.S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B virus. J. Hyg. (Lond.), 1972, Vol. 70, pp. 767-777.; Krivitskaya V.Z., Kuznetsova E.V., Maiorova V.G., Petrova E.R., Sominina A.A., Danilenko D.M. Influenza vaccination influencing level of specific humoral immunity in healthy individuals. Russian Journal of Infection and Immunity, 2022, Vol. 12, no. 1, pp. 127-141. (In Russ.) doi:10.15789/2220- 7619-IVI-1750.; Manenti A., Tete S.M., Mohn K. G.-I., Jul-Larsen Å., Gianchecchi E., Montomoli E., Brokstad K.A., Cox R.J. Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination. Vaccine, 2017, Vol. 35, pp. 191-198.; Nayak J., Hoy G., Gordon A. Influenza in children. Cold Spring Harb. Perspect. Med., 2021, Vol. 11, a038430. doi:10.1101/cshperspect.a038430; Ng S., Fang V.J., Ip D.K., Chan K.-H., G.M., Peiris J.S.M., Cowling B.J. Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children. J. Infect. Dis., 2013, Vol. 208, no. 8, pp. 1320-1324.; Nuñez I.A., Carlock M.A., Allen J.D., Owino S.O., Moehling K.K., Nowalk M.P., Susick M., Diagle K., Sweeney K., Mundle S., Vogel T.U., Delagrave S., Ramgopal M., Zimmerman R.K., Kleanthous H., Ross T.M. Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains. PLoS One, 2017, Vol. 12, no. 11, e0185666. doi:10.1371/journal.pone.0185666.; Oh Y.N., Kim S., Choi Y.B., Woo S.I., Hahn Y.-S., Lee J.K. Clinical similarities between influenza A and B in children: a single-center study, 2017/18 season. BMC Pediatr., 2019, Vol. 19, 472. doi:10.1186/s12887-019-1862-3.; Özkaya P.Y.,Turanli E.E., Metin H., Uysal A.A., Çiçek C., Karapinar B. Severe influenza virus infection in children admitted to the PICU: Comparison of influenza A and influenza B virus infection. J. Med. Virol., 2022, Vol. 94, pp. 575-581.; Potter C.W., Oxford J.S. Determinants of immunity to influenza infection in man. Br. Med. Bull., 1979, Vol. 35, no. 1, pp. 69-75.; Study of population immunity against influenza in the population of the Russian Federation: methodical guideline МУ 3.1.3490-17. Approved by the Chief State Sanitary Doctor of the Russian Federation on October 27, 2017. (In Russ.) Available at: https://www.garant.ru/products/ipo/prime/doc/71723602/.; Tsang T.K., Cauchemez S., Perera R.A., Freeman G., Fang V.J., Ip D.K., Leung G.M., Peiris J.S., Cowling B.J. Association between antibody titers and protection against influenza virus infection within households. J. Infect. Dis., 2014, Vol. 210, no. 5, pp. 684-692.; Williams K.V., Zhai B., Alcorn J.F., Nowalk P., Levine M.Z., Kim S.S., Flannery B., Geffel K.M., Merranko A.J., Nagg J.P., Collins M., Susick M., Clarke K.S., Zimmerman R.K., Martin J.M. A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults. Vaccine, 2022, Vol. 40, no. 5, pp. 780-788.; https://www.mimmun.ru/mimmun/article/view/2737
-
2Academic Journal
Συγγραφείς: N. P. Kolosova, T. N. Ilyicheva, S. V. Svyatchenko, A. V. Danilenko, G. S. Onkhonova, K. I. Ivanova, I. M. Susloparov, A. B. Ryzhikov, Н. П. Колосова, Т. Н. Ильичева, С. В. Святченко, А. В. Даниленко, Г. С. Онхонова, К. И. Иванова, И. М. Суслопаров, А. Б. Рыжиков
Συνεισφορές: Rospotrebnadzor, Роспотребнадзор
Πηγή: Medical Immunology (Russia); Том 24, № 6 (2022); 1219-1226 ; Медицинская иммунология; Том 24, № 6 (2022); 1219-1226 ; 2313-741X ; 1563-0625
Θεματικοί όροι: чувствительность к антинейраминидазным ингибиторам, seasonal, population immunity, hemagglutination inhibition reaction, molecular genetic analysis, neuraminidase inhibitors, sensitivity, популяционный иммунитет, реакция торможения гемагглютинации, молекулярно-генетический анализ
Περιγραφή αρχείου: application/pdf
Relation: https://www.mimmun.ru/mimmun/article/view/2513/1616; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2513/9446; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2513/9448; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2513/9449; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2513/9450; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2513/9451; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2513/9452; Демидов А. Роспотребнадзор назвал число привитых от гриппа россиян // Газета.ru, 2021. – 9 нояб. [Электронный ресурс]. Режим доступа: https://www.gazeta.ru/social/news/2021/11/09/n_16821619.shtml?updated (Дата обращения: 26.04.2022).; Adlhoch С., Mook P., Lamb F., Ferland L., Melidou A., Amato-Gauci A.J., Pebody R., European Influenza Surveillance Network. Very little influenza in the WHO European Region during the 2020/21 season, weeks 40 2020 to 8 2021. Euro Surveill., 2021, Vol. 26, no. 11, 2100221. doi:10.2807/1560-7917.ES.2021.26.11.2100221.; Groves H.E., Piche-Renaud P., Peci A., Farrar D.S., Buckrell S., Bancej C., Sevenhuysen C., Campigotto A., Gubbay J.B., Morris S. The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study. Lancet Reg. Health Am., 2021, Vol. 1, 100015. doi:10.1016/j.lana.2021.100015.; Huang W., Li X., Tan M., Cheng Y., Chen T., Wei H., Zeng X., Xie Y., Liu J., Xiao N., Yang L., Wang D. Epidemiological and Virological Surveillance of Seasonal Influenza Viruses – China, 2020-2021. China CDC Wkly, 2021, Vol. 3, no. 44, pp. 918-922.; Kolosova N.P., Ilyicheva T.N., Danilenko A.V., Bulanovich J.A., Svyatchenko S.V., Durymanov A.G., Goncharova N.I., Gudymo A.S., Shvalov A.N., Susloparov I.M., Marchenko V.Y., Tregubchak T.V., Gavrilova E.V., Maksyutov R.A., Ryzhikov A.B. Severe cases of seasonal influenza in Russia in 2017-2018. PLoS One, 2019, Vol. 14, no. 7, e0220401. doi:10.1371/journal.pone.0220401.; Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv: Genomics, 2013. doi:10.48550/arXiv.1303.3997.; Meetings of the WHO working group on surveillance of influenza antiviral susceptibility – Geneva, November 2011 and June 2012. Weekly Epidemiol. Rec., 2012, Vol. 87, no. 39, pp. 369-374.; Petersen E., Koopmans M., Go U., Hamer D.H., Petrosillo N., Castelli F., Storgaard M., Al Khalili S., Simonsen L. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect. Dis., 2020, Vol. 20, no. 9, pp. e238-e244.; Svyatchenko S.V., Goncharova N.I., Marchenko V.Yu., Kolosova N.P., Shvalov A.N., Kovrizhkina V.L., Durymanov A.G., Onkhonova G.S., Tregubchak T.V., Susloparov I.M., Gudymo A.S., Ilyicheva T.N., Ryzhikov A.B. An influenza A(H5N8) virus isolated during an outbreak at a poultry farm in Russia in 2017 has an N294S substitution in the neuraminidase and shows reduced susceptibility to oseltamivir. Antiviral Res., 2021, Vol. 191,105079. doi:10.1016/j.antiviral.2021.105079.; Weekly Epidemiological Record. 22 October 2021, Vol. 96, no, 42, pp. 509-520.; WHO. Recommended composition of influenza virus vaccines for use in the 2021-2022 northern hemisphere influenza season (Feb 2021). Available at: https://cdn.who.int/media/docs/default-source/influenza/who-influenzarecommendations/vcm-northern-hemisphere-recommendation-2021-2022/202102_recommendation.pdf?sfvrsn=2af603d8_12&download=true (last updated: 28.04.2022).; WHO. Recommended composition of influenza virus vaccines for use in the 2022 southern hemisphere influenza season (Sept 2021). Available at: https://www.who.int/publications/m/item/recommended-compositionof-influenza-virus-vaccines-for-use-in-the-2022-southern-hemisphere-influenza-season (last updated: 28.04.2022).; WHO, February 2022. Available at: https://www.who.int/publications/m/item/recommended-compositionof-influenza-virus-vaccines-for-use-in-the-2022-2023-northern-hemisphere-influenza-season (last updated: 25.04.2022).; WHO Recommended composition of influenza virus vaccines for use in the 2022 southern hemisphere influenza season. Available at: https://cdn.who.int/media/docs/default-source/influenza/who-influenzarecommendations/vcm-southern-hemisphere-recommendation-2022/202109recommendation.pdf?sfvrsn=698a54b9_12&download=true (last updated: 25.04.2022).; WHO Recommended composition of influenza virus vaccines for use in the 2022-2023 northern hemisphere influenza season. Available at: https://cdn.who.int/media/docs/default-source/influenza/whoinfluenza-recommendations/vcm-northern-hemisphere-recommendation-2022-2023/202202_recommendation.pdf?sfvrsn=5c88e006_13&download=true (last updated: 25.04.2022).; https://www.mimmun.ru/mimmun/article/view/2513
-
3Academic Journal
Συγγραφείς: Petrova P.A., Konovalova N.I., Vassilieva A.D., Eropkina E.M., Ivanova A.A., Komissarov A.B., Eropkin M.Y., Danilenko D.M.
Συνεισφορές: Работа выполнена при поддержке гранта NU51IP000854-01 «Поддержание потенциала по надзору за гриппом», а также стипендии Президента Российской Федерации молодым ученым и аспирантам (Конкурс СП-2018).
Πηγή: Russian Journal of Infection and Immunity; Vol 9, No 5-6 (2019); 655-664 ; Инфекция и иммунитет; Vol 9, No 5-6 (2019); 655-664 ; 2313-7398 ; 2220-7619 ; 10.15789/2220-7619-2019-5-6
Θεματικοί όροι: influenza A(H3N2) viruses, hemagglutination inhibition test, microneutralization, antigenic properties, genetic properties, MUNANA-assay, вирусы гриппа А(H3N2), реакция торможения гемагглютинации, реакция микронейтрализации, антигенные свойства, генетические свойства, MUNANA-тест
Περιγραφή αρχείου: application/pdf
Relation: https://iimmun.ru/iimm/article/view/772/875; https://iimmun.ru/iimm/article/downloadSuppFile/772/2767; https://iimmun.ru/iimm/article/downloadSuppFile/772/2768; https://iimmun.ru/iimm/article/downloadSuppFile/772/2769; https://iimmun.ru/iimm/article/downloadSuppFile/772/2770; https://iimmun.ru/iimm/article/downloadSuppFile/772/2771; https://iimmun.ru/iimm/article/downloadSuppFile/772/2772; https://iimmun.ru/iimm/article/downloadSuppFile/772/2773; https://iimmun.ru/iimm/article/downloadSuppFile/772/2774; https://iimmun.ru/iimm/article/downloadSuppFile/772/2775; https://iimmun.ru/iimm/article/downloadSuppFile/772/2776; https://iimmun.ru/iimm/article/downloadSuppFile/772/2777; https://iimmun.ru/iimm/article/downloadSuppFile/772/2778; https://iimmun.ru/iimm/article/downloadSuppFile/772/4272; https://iimmun.ru/iimm/article/view/772
-
4Academic Journal
Θεματικοί όροι: соболь, реакция гемагглютинации (РГА), реакция торможения гемагглютинации (РТГА), diagnosis, титр антител, mink, норка, antibody titer, 3. Good health, reaction hemagglutination (RHA), sable, hemagglutination inhibition test (HAI), диагноз, parvovirus enteritis, парвовирусный энтерит
-
5Academic Journal
Συγγραφείς: ОЛЕФИР ЮРИЙ ВИТАЛЬЕВИЧ, МЕРКУЛОВ В.А., ВОРОБЬЁВА М.С., РУКАВИШНИКОВ А.В., БОНДАРЕВ В.П., ШЕВЦОВ В.А.
Περιγραφή αρχείου: text/html
-
6Academic Journal
Πηγή: Иммунология.
Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, КЛЕЩЕВОЙ ЭНЦЕФАЛИТ,ИММУНОГЛОБУЛИН ЧЕЛОВЕКА ПРОТИВ КЭ,ИММУНОГЛОБУЛИН G,РЕАКЦИЯ ТОРМОЖЕНИЯ ГЕМАГГЛЮТИНАЦИИ (РТГА),ИММУНОФЕРМЕНТНЫЙ АНАЛИЗ (ИФА),ТИТР АНТИТЕЛ,МЕТОД КОНА,ФРАКЦИОНИРОВАНИЕ,ЛЕЧЕНИЕ КЭ,ЭКСТРЕННАЯ ИММУНОПРОФИЛАКТИКА,ЭКСПЕРТИЗА НОРМАТИВНЫХ ДОКУМЕНТОВ,TICK-BORNE ENCEPHALITIS,HUMAN IMMUNOGLOBULIN AGAINST TBE,IMMUNOGLOBULIN G,THE REACTION OF HEMAGGLUTINATION-INHIBITION,ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA),ANTIBODIES,CON METHOD,FRACTIONATION,TBE TREATMENT,EMERGENCY IMMUNIZATION,EXAMINATION OF NORMATIVE DOCUMENTS, 3. Good health
Περιγραφή αρχείου: text/html
